Detalhe da pesquisa
1.
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.
N Engl J Med
; 389(21): 1935-1948, 2023 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37937763
2.
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
N Engl J Med
; 383(10): 931-943, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469185
3.
TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC.
Future Oncol
; 19(21): 1461-1472, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37249038
4.
Benefits and limitations of real-world evidence: lessons from EGFR mutation-positive non-small-cell lung cancer.
Future Oncol
; 17(8): 965-977, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33242257
5.
EGFR tyrosine kinase inhibitors for EGFR mutation-positive non-small-cell lung cancer: outcomes in Asian populations.
Future Oncol
; 17(18): 2395-2408, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855865
6.
Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: final analysis of the GioTag study.
Future Oncol
; 16(34): 2799-2808, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32854536
7.
Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: updated analysis of the observational GioTag study.
Future Oncol
; 15(25): 2905-2914, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31370698
8.
Predictive value of PD-L1 and other clinical factors for chemoimmunotherapy in advanced non-small-cell lung cancer.
Future Oncol
; 15(20): 2371-2383, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31354046
9.
Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: an observational study.
Future Oncol
; 14(27): 2861-2874, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30336693
10.
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6.
Lancet Oncol
; 16(7): 830-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26051236
11.
Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial.
Lung Cancer
; 154: 92-98, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33636453
12.
Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: a multicentre, open-label, phase 1 study.
Lancet Respir Med
; 8(6): 561-572, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31954624
13.
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors.
Eur J Cancer
; 124: 110-122, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31760310
14.
Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies.
Lung Cancer (Auckl)
; 10: 125-130, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32009824
15.
Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer.
Lung Cancer
; 132: 126-131, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31097085
16.
Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer.
J Clin Oncol
; 36(9): 841-849, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28841389
17.
Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer.
J Thorac Oncol
; 12(7): 1061-1070, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28428148
18.
Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non-small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria.
Eur J Cancer
; 82: 27-33, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28646771
19.
First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases.
J Thorac Oncol
; 11(3): 380-90, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26823294